Literature DB >> 874760

Uptake of acetazolamide by human erythrocytes in vitro.

S M Wallace, S Reigelman.   

Abstract

The binding of acetazolamide to human erythrocytes was studied in vitro. Blood and plasma samples were analyzed by electron-capture GLC. At 37 degrees, drug equilibrated between plasma and erythrocytes in approximately 40 min. The effect of plasma concentration on the steady-state level of drug within the erythrocytes was examined. Erythrocyte accumulation of acetazolamide appeared to be a composite of two processes: a nonlinear, saturable process and a linear, diffusion-controlled process. By appropriate linear transformation of the data, estimates of the data, estimates of the erythrocyte binding capacity and the dissociation constant for the drug were obtained.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874760     DOI: 10.1002/jps.2600660532

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Potential pitfalls in the conventional pharmacokinetic studies: effects of the initial mixing of drug in blood and the pulmonary first-pass elimination.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

2.  In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics.

Authors:  G R Iyer; R A Bellantone; D R Taft
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

3.  Pharmacokinetics of mefruside and two active metabolites in man.

Authors:  H L Fleuren; C P Verwey-van Wissen; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

4.  Pharmacokinetics of a single oral dose of hydroflumethiazide in health and in cardiac failure.-.

Authors:  O Brørs; S Jacobsen; E Arnesen
Journal:  Eur J Clin Pharmacol       Date:  1978-11-09       Impact factor: 2.953

5.  Pharmacokinetics of hydroflumethiazide during repeated oral administration to healthy subjects.

Authors:  O Brørs; S Jacobsen
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

6.  A Pharmacokinetic Study Examining Acetazolamide as a Novel Adherence Marker for Clinical Trials.

Authors:  Aidan J Hampson; Shanna Babalonis; Michelle R Lofwall; Paul A Nuzzo; Phillip Krieter; Sharon L Walsh
Journal:  J Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.153

7.  Structure-Activity Relationship Studies of Acetazolamide-Based Carbonic Anhydrase Inhibitors with Activity against Neisseria gonorrhoeae.

Authors:  Chad S Hewitt; Nader S Abutaleb; Ahmed E M Elhassanny; Alessio Nocentini; Xufeng Cao; Devon P Amos; Molly S Youse; Katrina J Holly; Anil Kumar Marapaka; Weiwei An; Jatinder Kaur; Aaron D Krabill; Ahmed Elkashif; Yehia Elgammal; Amanda L Graboski; Claudiu T Supuran; Mohamed N Seleem; Daniel P Flaherty
Journal:  ACS Infect Dis       Date:  2021-03-25       Impact factor: 5.084

8.  Erythrocytes as barriers for drug elimination in the isolated rat liver. I. Doxorubicin.

Authors:  H J Lee; W L Chiou
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

9.  Pethidine binding to blood cells and plasma proteins in old and young subjects.

Authors:  L Holmberg; I Odar-Cederlöf; J L Nilsson; M Ehrnebo; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 10.  Bacterial carbonic anhydrases: underexploited antibacterial therapeutic targets.

Authors:  Daniel P Flaherty; Mohamed N Seleem; Claudiu T Supuran
Journal:  Future Med Chem       Date:  2021-08-12       Impact factor: 4.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.